Sector pending / Biological Products, Except Diagnostic SubstancesUpdated 2026-05-10 22:07 UTC

FRA/RV7 stock hub

FRA/RV7 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

FRA/RV7is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.5B

Frankfurt Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

FRA/RV7

In the news

Latest news · FRA/RV7

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E8

P25 n/aP50 n/aP75 n/a

Trailing P/E23.9

P25 n/aP50 n/aP75 n/a

ROE153.6

P25 n/aP50 n/aP75 n/a

ROIC32.4

P25 n/aP50 n/aP75 n/a

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All FRA/RV7 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

210

Groups with data

Currency

USD

Showing 210 of 210 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	423
Employees Change	-23%
Employees Change Percent	-6.17
Enterprise value	EUR 8.2B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-05-10
Market cap	EUR 6.5B
Price	EUR 55.54
Price currency	EUR
Rev Per Employee	2,812,041.58x
Sic	2836
Symbol	fra/RV7
Website	https://halozyme.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	4.18%
EV Earnings	30.32x
EV/EBIT	11.8x
EV/EBITDA	10.62x
EV/FCF	14.9x
EV/Sales	6.9x
FCF yield	8.51%
Forward P/E	8.05x
P/B ratio	155.24x
P/E ratio	23.91x
P/S ratio	5.43x
PE Ratio10 Y	30.58x
PE Ratio3 Y	18.49x
PE Ratio5 Y	20.41x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	58.45%
EBITDA Margin	64.29%
FCF margin	46.15%
Gross margin	77.78%
Gross Profit	EUR 925.2M
Gross Profit Growth	39.84%
Gross Profit Growth Q	44.83%
Gross Profit Growth3 Y	33.73%
Gross Profit Growth5 Y	41.73%
Net Income	EUR 269.9M
Net Income Growth	-28.64%
Net Income Growth3 Y	16.17%
Net Income Growth5 Y	19.68%
Pretax Margin	33.43%
Profit Margin	22.69%
Profit Per Employee	EUR 638,048
ROA	22.24
Roa5y	16.99
ROCE	34.76
ROE	153.6
Roe5y	183.2
ROIC	32.36
Roic5y	44.43

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	20.98%
Cagr15y	18.72%
Cagr20y	17.65%
Cagr3y	25.9%
Cagr5y	7.06%
EPS Growth	-25.36
EPS Growth3 Y	21.14
EPS Growth5 Y	22.98
FCF Growth	37.62%
FCF Growth Q	24.05%
FCF Growth3 Y	39.92%
FCF Growth5 Y	64.85%
OCF Growth	36.01%
OCF Growth Q	22.73%
OCF Growth3 Y	39.48%
OCF Growth5 Y	63.68%
Revenue Growth	37.55x
Revenue Growth Q	51.6x
Revenue Growth3 Y	28.38x
Revenue Growth5 Y	39.16x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	EUR 0.61
Assets	EUR 2.2B
Cash	EUR 121.6M
Current Assets	EUR 699.7M
Current Liabilities	EUR 150.2M
Debt	EUR 1.9B
Debt EBITDA	EUR 2.4
Debt Equity	EUR 44.6
Debt FCF	EUR 3.38
Equity	EUR 41.6M
Interest Coverage	45.03
Liabilities	EUR 2.1B
Long Term Assets	EUR 1.5B
Long Term Liabilities	EUR 2B
Net Cash	EUR -1.7B
Net Cash By Market Cap	EUR -26.85
Net Debt EBITDA	EUR 2.27
Net Debt Equity	EUR 41.68
Net Debt FCF	EUR 3.16
Tangible Book Value	EUR -1.3B
Tangible Book Value Per Share	EUR -10.94

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.66
Inventory Turnover	1.95
Net Working Capital	EUR 440M
Quick ratio	3.3
Working Capital	EUR 552M
Working Capital Turnover	EUR 1.49

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	4.27%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	571.67%
200-day SMA	58.73
3Y total return	99.57%
50-day SMA	56.37
50-day SMA vs 200-day SMA	50under200
5Y total return	40.61%
All Time High	68.84
All Time High Change	-19.32%
All Time High Date	2026-02-09
All Time Low	1.16
All Time Low Change	4,687.93%
All Time Low Date	2005-04-19
ATR	0.89
Ch YTD	-4.67
High	55.54
High52	68.84
High52 Date	2026-02-09
High52ch	-19.32%
Low	55.54
Low52	42.45
Low52 Date	2025-05-15
Low52ch	30.84%
Ma50ch	-1.47%
Price vs 200-day SMA	-5.43%
RSI	47.08
RSI Monthly	53.55
RSI Weekly	45.9
Sharpe ratio	-0.11x
Sortino ratio	-0.02
Total Return	4.27%
Tr YTD	-4.67
Tr15y	1,212.07%
Tr1m	2.1%
Tr1w	3.27%
Tr3m	-15.85%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR 695.2M
Operating Income Growth	48.02
Operating Income Growth Q	44.95
Operating Income Growth3 Y	41.29
Operating Income Growth5 Y	41.43
Operating margin	58.45

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	117,160,177%
Net Borrowing	529,615,018.2
Shares Insiders	1.02%
Shares Institutions	106.3%
Shares Qo Q	-3.81%
Shares Yo Y	-4.27%
Short Ratio	8.9

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR 505.1M
Average Volume	37.35x
Bv Per Share	0.35
CAPEX	EUR -5.9M
Ch10y	571.7
Ch15y	1,212.1
Ch1m	2.1
Ch1w	3.27
Ch20y	2,483.3
Ch3m	-15.85
Ch3y	99.57
Ch5y	40.61
Ch6m	-6.78
Change	-1.98%
Change From Open	0
Close	56.66
Days Gap	-1.98
Depreciation Amortization	69,152,149.1
Earnings Date	2026-05-11
EBIT	EUR 695.2M
EBITDA	EUR 764.7M
EPS	EUR 2.18
F Score	6
FCF	EUR 549M
FCF EV Yield	6.71x
Financing CF	-72,542,696
Fiscal Year End	December
Founded	1,998
Goodwill	492,123,226.3
Graham Number	4.32392
Graham Upside	-92.21
Income Tax	EUR 127.7M
Investing CF	-464,868,932
Is Primary Listing	0
Last Earnings Date	2026-02-17
Last Report Date	2025-12-31
Lynch Fair Value	EUR 45.7
Lynch Upside	-17.72
Ma150	58.53
Ma150ch	-5.11%
Ma20	56.55
Ma20ch	-1.78%
Net CF	17,520,321
Next Earnings Date	2026-05-11
Open	55.54
P FCF Ratio	11.76
P OCF Ratio	11.63
Ppne	69,649,054.8
Price Date	2026-05-08
Price EBITDA	EUR 8.44
Relative Volume	3.09x
Revenue	1,189,493,589x
SBC By Revenue	3.69x
Share Based Comp	43,917,911
Tax By Revenue	10.74x
Tax Rate	32.13%
Tr20y	2,483.26%
Tr6m	-6.78%
Z Score	3.78

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does FRA/RV7 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/RV7 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns FRA/RV7?

Insider, institutional, and short-interest positioning.

Institutional ownership

+106.3%

Share of float held by funds and institutions

Insider ownership

+1.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

FRA/RV7 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

47.1

Neutral momentum band

Price vs 200-day MA

-5.4%

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

-0.11

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About FRA/RV7

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/RV7 stock rating?

fra/RV7 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/RV7 analysis?

The full report lives at /stocks/fra/RV7/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/RV7?

The latest report frames fra/RV7 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/RV7 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.